Cargando…
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate
The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded molecules parallel to the [111] crystallographic direction and by stacking interactions between ring...
Autores principales: | Bambagiotti-Alberti, Massimo, Bartolucci, Gianluca, Bruni, Bruno, Coran, Silvia, Di Vaira, Massimo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961024/ https://www.ncbi.nlm.nih.gov/pubmed/21202108 http://dx.doi.org/10.1107/S1600536808005308 |
Ejemplares similares
-
N-(1,4-Dioxo-1,4-dihydronaphthalen-2-yl)benzamide
por: Brandy, Yakini, et al.
Publicado: (2012) -
tert-Butyl N-{3-[(3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino]propyl}carbamate
por: Resende, Jackson A. L. C., et al.
Publicado: (2012) -
N-(3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-propionylpropionamide
por: Idris, Nabil, et al.
Publicado: (2014) -
Diisopropyl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]ethyl}ammonium hydrogen sulfate
por: Bambagiotti-Alberti, Massimo, et al.
Publicado: (2008) -
1-Cyclohexyl-6,7-dimethoxy-1,4-dihydronaphthalene
por: Chen, Shao-Yuan, et al.
Publicado: (2014)